Background
==========

Schistosomiasis is a debilitating chronic infection caused by trematode worms of the genus *Schistosoma*. Rural regions in the tropics are most affected leading to a global disease burden of 3--70 million disability-adjusted life years lost \[[@B1]\]. Humans become infected during freshwater exposure by larval stages of *Schistosoma* spp. (cercariae) shed from the snail intermediate host. Cercariae penetrate the intact skin, migrate to and evolve in the venous drainage systems of several tissues in the human host, including the urogenital tract (*S. haematobium*) and the intestines (*S. mansoni, intercalatum, japonicum, mekongi*). The presence of adult worms and their eggs in human tissues ultimately lead to a variety of chronic pathologies including haematuria, haematochaezia, liver fibrosis, bladder cancer, and chronic inflammation of the urogenital tract \[[@B2]\].

Katayama fever is an acute inflammatory syndrome resulting in high fever, cough and general malaise, occurring 3--8 weeks after infection by cercariae, that has chiefly been described in travellers from non-endemic regions \[[@B3]\]. The clinical symptoms of Katayama fever are mediated by a hypersensitivity reaction to the intravascular trematodes. Acute clinical symptoms gradually subside even without specific anthelmintic treatment and are superseded by chronic granulomatous inflammation which causes the vast majority of morbidity.

Although several studies have investigated the immunological aspects of chronic *Schistosoma* infection in animal models and humans, little is known about inflammatory markers and radiological signs of inflammation in Katayama fever \[[@B4]\]. No data describing the consequences of intravascular helminth migration on the activation of blood coagulation mechanisms in Katayama fever have been published so far. Here we report the clinical course, radiological findings, and observed alterations in markers of inflammation and blood coagulation in three returning travellers suffering from Katayama fever.

Methods
=======

Patients were initially assessed at three different hospitals in Eastern Austria. Two patients were subsequently hospitalized at the Division of Infectious Diseases and Tropical Medicine at the Medical University of Vienna, and the third patient was hospitalized at a referral hospital in the province of Upper Austria. Written informed consent was obtained from patients for additional blood sampling for the analysis of coagulation parameters and for permission to analyse clinical data. Ethical clearance was waived for this case series by the institutional review board of the Medica University of Vienna. Radiological evaluation of patients was performed at the referring hospitals. D-dimer, *in-vitro* thrombin generation potential and microparticle-associated tissue factor (MP-TF) activity measurements were performed at the Medical University of Vienna using previously validated assays \[[@B5],[@B6]\]. Inflammatory markers were assessed using internally and externally quality-controlled standard methods. Data were captured in an electronic database; due to the small sample size, original data were reported and non-parametric summary measures were presented as appropriate.

Results
=======

Clinical presentations of patients and radiological findings
------------------------------------------------------------

Two female and one male Austrian citizen aged 19--21 years all presented at hospitals in Eastern Austria with an abrupt onset of general malaise, high fever and a productive cough. All patients had returned from a four-week trip to the Republic of Tanzania three weeks prior to the onset of symptoms. The journey consisted of work in a developmental aid programme in a rural community, a game park visit and freshwater exposure in Lake Malawi. On admission, they were all treated empirically with broad-spectrum beta-lactam antibiotics for suspected pneumonia. The two female patients were subsequently transferred to the inpatient ward of the Department of Infectious Diseases at the Medical University of Vienna due to progressive clinical deterioration. The male patient was hospitalized at a referral hospital in the province of Upper Austria.

On referral, the diagnosis of Katayama fever was made based on the clinical history, laboratory parameters and radiological findings. Anti-inflammatory treatment with corticosteroids and concomitant anthelminthic treatment with praziquantel were administered. Patients responded rapidly to this treatment and were discharged within five days. Malaria and systemic bacterial or fungal infections were excluded with serial, negative thick blood smears and blood cultures. Out-patient follow-up visits were performed over a six month period. *Schistosoma-*specific antibody titres -- initially negative during the acute phase of infection -- later converted to a positive result in all three patients and confirmed the initial clinical diagnosis. No urinary/faecal excretion of *Schistosoma* eggs was detected during follow-up in any of the patients. A second cycle of praziquantel treatment was administered three months after initial presentation to target previously immature stages, which are less susceptible to praziquantel.Chest X-rays in all patients did not show pathological changes. A slightly enlarged spleen on abdominal ultrasound was documented in one case (14.4 cm diameter). In one patient, thoracic and abdominal CT was performed at the referring hospital due to the clinical diagnosis of systemic inflammatory response syndrome. This revealed multiple, bilateral pulmonary opacities measuring up to 9 mm (Figure [1](#F1){ref-type="fig"}), and hypodense foci in the liver (Figure [2](#F2){ref-type="fig"}). These radiological findings were initially reported as being consistent with numerous septic abscesses or metastatic malignancy.

![Radiographic findings of lung computed tomography during Katayama syndrome (axial (A) and coronal (B) reconstruction).](1471-2334-14-357-1){#F1}

![Radiographic findings of abdominal computed tomography during Katayama syndrome (axial (A) and coronal (B) reconstruction).](1471-2334-14-357-2){#F2}

Characterisation of inflammatory response and blood coagulation parameters
--------------------------------------------------------------------------

Clinical and laboratory markers of inflammation were repeatedly assessed during follow-up of patients (Table [1](#T1){ref-type="table"}) All individuals experienced high fever \>39°C at initial presentation. Classical markers of inflammation including C-reactive protein (CRP; range: 6--23 mg/L), serum amyloid A (SAA; 52--67 mg/L), and blood sedimentation rate (BSR; 27/36--82/110 mm/h) were moderately elevated. Correspondingly, the total leukocyte count was elevated, with a marked eosinophilia ranging between 33-42% of white blood cells observed in all patients. Inflammatory markers rapidly returned to normal levels after the initiation of anti-inflammatory treatment with corticosteroids; however, eosinophilia only gradually declined and persisted for up to 32 weeks after the initiation of treatment. Elevated lactate dehydrogenase (LDH) levels were present in one patient with a particularly pronounced inflammatory response (391 U/L).

###### 

Clinical and laboratory markers of inflammation at initial presentation and during follow-up

  **Parameter**                   **Patient**   **Baseline**   **Week 1**   **Week 2**   **Week 6**   **Week 11**   **Week 32**
  ------------------------------- ------------- -------------- ------------ ------------ ------------ ------------- -------------
  Temperature (°C)                A             max 39.0       \<37         \<37         \<37         \<37          \<37
                                  B             max 39.6       \<37         \<37         \<37         \<37          \<37
                                  C             max 39.3       \<37         \<37         \<37         \<37          \<37
  BSR (mm)                        A             55/82          \-           31/60        7/22         12/22         12/20
                                  B             82/110         \-           64/102       12/28        14/31         15/31
                                  C             27/36          25/30        \-           \-           \-            \-
  CRP (\<10 mg/L)                 A             6              3            0.7          0.3          0.4           0.2
                                  B             23             10           6            1            1             2
                                  C             23             11           \-           \-           \-            \-
  PCT (\<0.5 ng/ml)               A             0.13           \-           \-           \-           \-            \-
                                  B             0.17           \-           \-           \-           \-            \-
                                  C             \-             \-           \-           \-           \-            \-
  SAA (\<5 mg/L)                  A             52             32           \-           \-           \-            \-
                                  B             67             31           \-           \-           \-            \-
                                  C             \-             \-           \-           \-           \-            \-
  LDH (\<247 U/L)                 A             192            173          206          189          149           157
                                  B             391            237          275          204          180           183
                                  C             200            202          \-           \-           \-            \-
  Leukocyte count (4--10 G/l)     A             5.9            8.5          2            5.4          4.7           5.2
                                  B             16.1           17.1         14.2         6.7          6.5           7.6
                                  C             12.7           11.9         \-           \-           \-            \-
  Eosinophil count (0--0.4 G/l)   A             2              3.1          1.2          0.4          0.3           0.2
                                  B             6.7            7.2          5.8          0.8          0.7           0.2
                                  C             4.5            4            \-           \-           \-            \-
  Eosinophil relative (0-4%)      A             33             36           15.1         7.4          6.0           3.8
                                  B             42             42           41           12           16            2.6
                                  C             35             33.5         \-           \-           \-            \-

max: maximum; BSR: blood sedimentation rat after one hour/after two hours; CRP: C-reactive protein; PCT: procalcitonin; SAA: serum amyloid A; LDH: lactate dehydrogenase.

Blood coagulation parameters were assessed in the two female patients (Table [2](#T2){ref-type="table"}). Here, D-dimer levels were elevated at presentation indicating activation of haemostasis and fibrinolysis (1.2 and 0.6 μg/mL, respectively), and fibrinogen levels were slightly increased (477--517 mg/L). The thrombin generating potential was increased at presentation as reflected by a higher peak measurements (384 and 311 nM, respectively) compared to follow-up. In one patient the peak thrombin generating potential was increased at the end of follow-up without evidence for disease activity. Finally, the MP-TF activity was markedly raised in one patient at 1.64 pg/mL, before gradually declining to 0.03 pg/mL.

###### 

Parameters of coagulation cascade at initial presentation and during follow up

  **Parameter**                   **Patient**   **Baseline**   **Week 1**   **Week 6**   **Week 11**   **Week 32**
  ------------------------------- ------------- -------------- ------------ ------------ ------------- -------------
  D-dimer (\<0.5 μg/ml)\*         A             0.57           0.06                                    0.28
  B                               1.17          1.21                                     0.46          
  Fibrinogen (180--390 mg/dl)     A             477            443          331          302           312
  B                               517           369            307          281          341           
  Peak thrombin generation (nM)   A             311            \-           190          169           122
  B                               384           \-             202          237          506           
  MP-TF activity (pg/ml)          A             0.09           \-           0.05         0             0.85
                                  B             1.64           \-           1.10         0.12          0.03

\*this cut-off indicates non-increased or negative D-dimer values.

MP-TF = microparticle-associated tissue factor.

Discussion
==========

Katayama fever is thought to be mediated by a systemic hypersensitivity reaction to migrating parasites and circulating immune complexes at the onset of egg production \[[@B4]\], leading to the classical clinical symptoms. The clinical presentation of the reported cases was indicative of such an inflammatory response - patients had a fever \>39°C and were significantly incapacitated by the clinical disease course. Contrary to these findings, however, inflammatory markers including CRP and BSR were only modestly elevated. At the same time eosinophilia -- a hallmark of invasive helminthic infections -- was markedly elevated. Interestingly, eosinophilia persisted for more than six months prior to normalisation indicating prolonged exposure to helminthic antigen stimulation. This finding may be explained by the fact that praziquantel -- although already administered in our patients during acute infection -- has little activity against the early developmental stages of schistosomal worms and complete cure from all intravascular worms was therefore achieved only after re-administration of praziquantel during the follow up period \[[@B7]\].

Distinct radiographic abnormalities of the lungs in Katayama fever, including patchy pulmonary infiltrates on chest X-ray and single/multiple pulmonary nodules with ground-glass halos on CT, have been previously described \[[@B8]-[@B10]\]. However, radiological alterations in other viscera have been less well described. CT in one of our patients showed radiological alterations of the lung parenchyma consistent with previous reports. In addition, multiple hypodense foci were demonstrated in the liver supporting the hypothesis that Katayama fever represents are more generalized inflammatory response. Whereas these findings are useful from a scientific point of view, the authors are convinced that CT should not be considered as a standard diagnostic examination for patients with suspected Katayama fever, given that the CT features are not pathognomonic of this disease and the risks of exposure to radiation most likely outweigh the diagnostic benefit.

Detailed analysis of coagulation mechanisms including: D-dimer, which indicates an activation of haemostasis and fibrinolysis; the thrombin generation potential, a global in-vitro assay indicating an individual's coagulation potential; and measurement of the MP-TF activity, which reflect a prothrombotic state, showed considerable variability in these cases. One may speculate that the intravascular migration of helminths would result in activation of the coagulation cascade; this was demonstrated by increased levels of D-dimer, a high peak thrombin and a marked increase of the MP-TF activity in one patient. However, these features were less evident in a second patient, explained either by a less pronounced response in this patient or that the peak in alterations may have been missed during the referral from another hospital. Despite the intravascular localisation of schistosomal worms and the activation of coagulation mechanisms, clinical complications such as thrombotic events are not commonly reported in the context of acute schistosomiasis, consistent with our cases. A better understanding of the underlying mechanisms for this discordance of clinical and laboratory findings may improve our knowledge of the complex interplay between helminth pathogens and the host's response.

Conclusion
==========

The characterisation of the inflammatory response, coagulation parameters and description of corresponding radiographic findings in our patients may provide helpful information for the diagnostic workup of future patients with acute febrile conditions returning from the tropics. Based on these preliminary findings, a further systematic evaluation of the impact of intravascular helminth infection on blood coagulation and the inflammatory response in a larger, case-controlled study may be warranted.
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